Upcoming Events

PCR London Valves 2018
September 9 – 11, 2018
London, UK Explore

Tuesday, September 11, 2018
Location: ExCel London Contemporary Events & Convention Center
Room: 4
Procedural to three-year outcomes of the MAVERIC CE mark trial of transcatheter annular reduction therapy for functional mitral regurgitation
Time: 8:30am
Presented by S. Redwood, MD

TCT 2018
September 21 - 25, 2018
San Diego, USA Explore

Sunday, September 23, 2018
Location: San Diego Convention Center
ARTO Indirect Annuloplasty for Functional MR: Update and Case Presentation
Time: 5:26pm
Presented by Stephen G. Worthley, MD

Press Releases

Clinical trial outcomes show great promise for less-invasive therapy to help millions of heart failure patients suffering from mitral valve regurgitation - Read
BusinessWire, May 23, 2017

Several distinct learning opportunities for the ARTO System and its effectiveness in TART - Read
BusinessWire, May 12, 2017

MVRx overcomes past hurdles, moves forward with mitral valve treatment device - Read (Log in required)
Medical Device Daily, October 2, 2014

MVRx System to Combat Heart Failure Emerges from Stealth Mode - Read
BusinessWire, September 12, 2014

Presentations

MAVERIC: First Presentation of the 1 Year Follow-up of the Mitral Valve Repair Clinical Trial
EuroPCR 2018 - Paris, France
Presented by Simon Redwood, MD

Three Year Final Outcomes of the Phase I Mitral Valve Repair Clinical Trial (MAVERIC I) Using the ARTO System for the Treatment of Functional Mitral Regurgitation
EuroPCR 2017 - Paris, France
Presented by Andrejs Erglis, MD, PhD

The Mitral Valve Repair Clinical (MAVERIC) Trial
EuroPCR 2017 - Paris, France
Presented by Stephen Worthley, MD, PhD

Symposium:Transcatheter Annular Reduction Theraphy (TART) for functional mitral regurgitation: An Introduction to the ARTO System
EuroPCR 2017 - Paris, France
  • Functional Mitral Regurgitation and the ARTO™ Procedure
    Presented by B. Prendergast, MD
  • ARTO™ System Case Presentation
    Presented by S. Redwood, MD
  • The MAVERIC Experience: Early and Long-Term Results
    Presented by S. Worthley, MD, PhD
  • Clinical Programme Update
    Presented by J. Rogers, MD

MVRx ARTO System
PCR London Valves 2016 - London, UK
Presented by David Hildick-Smith, MD

MVRx ARTO System Procedure and MAVERIC Trial Update
TCT 2016 - Washington, DC
Presented by David Hildick-Smith, MD

Mitral valve repair using a novel percutaneous septal sinus shortening device
EuroPCR 2016 - Paris, France
Presented by Ganesh Manoharan, MD

MVRx ARTO System (Septal Sinus Shortening) and the MAVERIC Trial
TCT 2015 - San Francisco, CA, USA
Presented by Andrejs Erglis, MD, PhD

Edited Taped Cases 1: Novel Valve and Structural Heart Procedures - ARTO System - Watch video below
TCT 2015 - San Francisco, CA, USA
Presented by Andrejs Erglis, MD, PhD

 

Results of the Multi-Centre Phase of the MAVERIC Trial
PCR London Valves 2015 - Berlin, Germany
Presented by Ganesh Manoharan, MD

MVRx - Percutaneous Repair of CHF-Related Mitral Regurgitation
PCF Innovator's Day 2015 - Paris, France

6 Month MAVERIC Study Results
EuroPCR 2015 - Paris, France
Presented by Andrejs Erglis, MD, PhD

ARTO System Case Study
EuroPCR 2015 - Paris, France

ARTO System Overview
EuroPCR 2015 - Paris, France

Septolateral Cinching ll: MVRX
TVT 2015 - Chicago, IL, USA

MVRx: A Novel New Transcatheter system to treat functional mitral regurgitation
PCR London Valves 2014 - London, UK
Presented by Martyn Thomas, MD

30 Day Results of MAVERIC Trial
TCT 2014 - Washington DC, USA
Presented by Andrejs Erglis, MD, PhD

In Press

MAVERIC: Transcatheter Mitral Valve Repair System Confers 6-Month Benefit - Read
Healio, Novemeber 8, 2017

Pioneering Heart Op is Lifesaver for Mother - Read
South London Press, Novemeber 7, 2017

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months - Read
TCTMD, Novemeber 6, 2017

Tiny 'Anchor' to Fix Leaky Heart Valves - Without Surgery: New Implant Keeps it in Place to Help Restore Blood Flow - Read
Daily Mail, October 31, 2017

Announcing the TCT 2017 Late-Breaking Trials and First Report Investigations - Read
Newswise, September 12, 2017

Publications

Treatment of Secondary Mitral Regurgitation in Chronic Heart Failure - Read
Erglis et al, Journal of the American College of Cardiology, December, 2017

TCT-461 6 Month Outcomes of Transcatheter Annular Reduction Therapy (TART) with ARTO™ System for Functional Mitral Regurgitation - Read
Worthley et al, Journal of the American College of Cardiology, October, 2017

The ARTO Transcatheter Mitral Valve Repair System
Erglis et al, EuroIntervention, September, 2015

Treatment of Heart Failure With Associated Functional Mitral Regurgitation Using the ARTO System
Rogers et al, JACC Cardiovasc Interv. 2015 Jul;8(8):1095-104

Long-Term Safety and Durability of Percutaneous Septal Sinus Shortening - Read
Rogers et al, Catheterization and Cardiovascular Interventions, March, 2009

Safety and Feasibility of Acute Percutaneous Septal Sinus Shortening - Read
First-in-human experience
Palacios et al, Catheterization and Cardiovascular Interventions, March, 2007

Percutaneous Septal Sinus Shortening
A Novel Procedure for the Treatment of Functional Mitral Regurgitation
Rogers et al, Circulation. 2006;113:2329-2334